
|Articles|November 1, 2018
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Pharm Exec's 2019 Pipeline Reportalmost 8 years ago
High-Risk Marketing Violations Draw Scrutinyalmost 8 years ago
Biopharma Business Checkalmost 8 years ago
Patent Protection for Cannabis?almost 8 years ago
Steadying the Path of Good Sciencealmost 8 years ago
Southeast Biotech: Rising Tall in the Valleyalmost 8 years ago
Fighting for a Streamlined European HTA Schemealmost 8 years ago
Stunted Innovation in Drug Development?almost 8 years ago
Country Report: AlgeriaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
3
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
4
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
5




